Comparison of multiple estimates of efficacy for influenza vaccine

Vaccine

Volumn 30, Issue 1, 2011, Pages 1-4

  Loeb, Mark ^a,b   Russell, Margaret L ^c   Fonseca, Kevin ^c   Webby, Richard ^d   Walter, Stephen D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Herd effects; Influenza; Vaccine

Indexed keywords

HEPATITIS A VACCINE; INFLUENZA VACCINE; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; CHILD; CONFIDENCE INTERVAL; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; ADULT; AGED; COMPARATIVE STUDY; FEMALE; HERD IMMUNITY; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; INFLUENZA; MALE; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNITY, HERD; IMMUNOLOGIC TECHNIQUES; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 84858611364     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.069     Document Type: Article

References (15)

1. Demicheli V, Di Pietrantonj C, Jefferson T, Rivetti A, Rivetti D. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2007;2, doi:10.1002/14651858.
2. Halloran ME, Longini Jr IM, Struchiner CJ. Design and interpretation of vaccine filed studies. Epidemiol Rev 1999;21:73-88.
3. Basta NE, Halloran ME, Matrajt L, Longini Jr I. Estimating influenza vaccine efficacy from challenge and community-based study data. Am J Epidemiol 2008;168:1343-52.
4. Monto A, Davenport FM, Napier JA, Francis T. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of school children. J Infect Dis 1970;122:16-25.
5. Esposito S, Marchisio P, Cavagna R, et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine 2003;21: 3162-8.
6. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-like illnesses with use of the trivalent-live attenuated influenza vaccine [CAIV-T] in children. Vaccine 2005:1540-8.
7. Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating school children against influenza. N Engl J Med 2001;344: 889-96.
8. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000;284:1677-82.
9. Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 1993;168:881-7.
10. King Jr JC, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006;355:2523-32.
11. Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in hutterite communities: a randomized control trial. JAMA 2010;303(10):943-50.
12. Dawood FS, Jain S, Finelli L, et al. Novel swine-origin influenza A [H1N1] virus in vaccine efficacy for susceptibility litigation team. Emergence of a novel swine-origin influenza A [H1N1] virus in humans. N Engl J Med 2009;360: 2605-15.
13. National Advisory Committee on Immunization. Statement on seasonal trivalent inactivated influenza vaccine [TIV] for 2009-2010. Canada Communicable Disease Report 2009;35(ACS-6):1-41, http://www.phacaspc. gc.ca/publicat/ccdr-rmtc/09vol35/acs-dcc-6/index-eng.php [accessed 5.01.2011].
14. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
15. Wei LJ, Lin DY, Weissfeld L. Regression-analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065-73.